Neurological Disorders

📚 02 Pediatric Superspecialities • 🎯 204 High-Yield MCQs • Nelson 22nd Edition Standard

Congenital Spinal Anomalies & Neural Tube Defects (NTDs)

  • Cutaneous Markers of Occult Spinal Dysraphism: ((NEUR001)): Occult spinal dysraphism presents with lumbosacral skin lesions including hair tufts, dermal sinus tracts, and skin tags (indicating tethered cord or lipomyelomeningocele). Coccygeal pits are common, benign variants and are not associated with NTDs.
  • Etiology of Neural Tube Defects: ((((NEUR002)) · ((NEUR026)))): NTDs arise from failed primary neurulation (3–4 weeks postgestation). Key risk factors include maternal hyperthermia, valproic acid, and malnutrition/suboptimal folate. Maternal hypothermia is not a risk factor. Detected prenatally by elevated alpha-fetoprotein; cell-free fetal DNA (cfDNA) screening cannot detect NTDs ((NEUR027)).

Epilepsy Syndromes & Anti-Seizure Medications (ASMs)

  • Febrile Seizure Prognosis: ((NEUR003)): Risk factors for subsequent epilepsy following febrile seizures include developmental delay, family history of epilepsy, and prolonged or focal seizures. The height of the temperature (degree of fever) predicts recurrence risk but not subsequent epilepsy.
  • Dravet Syndrome: ((NEUR004)): Severe epileptic encephalopathy caused by SCN1A gene mutations, typically presenting after prolonged febrile seizures triggered by vaccination or illness. Sodium channel blockers (lamotrigine, carbamazepine, phenytoin) worsen seizures and must be avoided.
  • Lennox-Gastaut Syndrome (LGS): ((NEUR018)): Epileptic encephalopathy characterized by the clinical triad of multiple seizure types (tonic, atonic drop attacks, atypical absence), cognitive impairment, and an EEG showing 1–2 Hz slow generalized spike-and-wave discharges.
  • Myoclonic Seizures and ASM Selection: ((NEUR014)): Lamotrigine can paradoxically worsen myoclonic seizures (as in JME or Dravet syndrome). Preferred agents for myoclonus include valproate, levetiracetam, and clonazepam.
  • Adverse Effects of ASMs: ((((NEUR009)) · ((NEUR013)))): Valproate causes weight gain, tremor, hair loss, hepatotoxicity, and PCOS (weight loss is incorrect). Topiramate causes anorexia, renal stones, oligohidrosis/hyperthermia, and hyperammonemia (especially when combined with valproate).

Metabolic & Leukodystrophy Disorders

  • Adrenoleukodystrophy (ALD): ((NEUR005)): X-linked peroxisomal disorder caused by ABCD1 gene mutations leading to tissue accumulation of very long-chain fatty acids (VLCFAs). Loes scoring on MRI quantifies disease progression.
  • Wilson Disease: ((NEUR006)): Autosomal recessive disorder caused by pathogenic variants in ATP7B impairing biliary copper excretion. Diagnosed using the Leipzig score (>4 makes it highly likely). Symptom onset before 3 years of age is exceedingly rare; Kayser-Fleischer rings are absent in >10% of pediatric hepatic presentations.
  • Cerebrotendinous Xanthomatosis (CTX): ((NEUR020)): Lipid storage disorder due to CYP27A1 gene mutations causing sterol 27-hydroxylase deficiency and cholestanol accumulation. Treated with chenodeoxycholic acid.
  • Infantile Tremor Syndrome: ((NEUR033)): Presents with developmental regression, coarse tremors, and anemia between 6–18 months of age. Associated with deficiencies of vitamin B12, iron, zinc, and magnesium (vitamin D deficiency is not a cause).

Movement Disorders & Mitochondrial Cytopathies

  • Segawa Disease (Dopa-Responsive Dystonia): ((NEUR007)): Caused by mutations in GCH1 (tetrahydrobiopterin deficiency). Responsive to L-DOPA, but its efficacy is decreased by co-administration with pyridoxine (vitamin B6) due to peripheral conversion.
  • Alternating Hemiplegia of Childhood (AHC): ((NEUR017)): Caused by mutations in ATP1A3 (Na+/K+-ATPase pump dysfunction). Characterized by episodic hemiplegia, dystonia, and choreoathetosis that disappear during sleep. Treated prophylactically with flunarizine.
  • Episodic Ataxia Type 2 (EA2): ((NEUR015)): Caused by CACNA1A mutations (P/Q-type calcium channel). Attacks of ataxia last hours (not seconds-to-minutes; the latter applies to EA1 with myokymia). Responsive to acetazolamide.
  • Kearns-Sayre Syndrome (KSS): ((NEUR019)): Mitochondrial cytopathy caused by large-scale mtDNA deletions presenting before age 20 with progressive external ophthalmoplegia (PEO), pigmentary retinopathy, and complete heart block.
  • Leber Hereditary Optic Neuropathy (LHON): ((NEUR034)): Mitochondrial disorder (frequently MT-ND4 mutations) for which successful trials of adeno-associated virus gene replacement have been published.

Neurocutaneous Syndromes

  • Neurofibromatosis Type 1 (NF1): ((NEUR008)): Cutaneous hallmark includes café-au-lait macules. Plexiform neurofibromas are congenital and may be evident at birth, whereas axillary/inguinal freckling and discrete neurofibromas appear later in childhood.
  • Tuberous Sclerosis Complex (TSC): ((NEUR032)): Requires rigorous surveillance including brain MRI every 1–3 years (for SEGA monitoring) and abdominal MRI every 1–3 years (for renal angiomyolipomas), even in asymptomatic patients.

Infections, Encephalopathies & Post-Infectious CNS Conditions

  • Complications of Bacterial Meningitis: ((NEUR010)): Sensorineural hearing loss is the single most common long-term complication, highest in Streptococcus pneumoniae (~30%).
  • Post-Infectious Cerebellar Ataxia: ((NEUR012)): Abrupt onset of truncal ataxia 2–3 weeks after viral illness (e.g., varicella). Characterized by normal sensorium, absence of fever/meningismus, and normal brain MRI.
  • Acute Necrotizing Encephalopathy of Childhood (ANEC): ((NEUR035)): Rapid encephalopathy following viral illness with symmetric multifocal lesions involving bilateral thalami. CSF shows no pleocytosis/protein elevation. Increased blood ammonia is an exclusion criterion (suggests a metabolic disorder).

Neuroimmunology & Parasomnias

  • Autoimmune Encephalitis Antibodies: ((((NEUR021)) · ((NEUR022)))): Faciobrachial dystonic seizures (FBDS) are pathognomonic for anti-LGI1 encephalitis (often accompanied by hyponatremia). GAD is an intracellular enzyme antibody, unlike cell-surface/neuronal membrane antibodies (NMDA, AMPA, LGI1).
  • Parasomnias of Arousal: ((NEUR024)): Night terrors (pavor nocturnus) arise from non-REM slow-wave sleep (stage N3) during the first third of the night, characterized by autonomic surge, intense fear, unresponsiveness, and subsequent amnesia.
  • Narcolepsy Type 2: ((NEUR023)): Features excessive daytime sleepiness and multiple SOREMPs on MSLT, but cataplexy is absent and CSF hypocretin levels are typically normal.

Critical Care & Neurological Determination of Death

  • Brain Death Ancillary Tests: ((NEUR025)): Valid ancillary tests for confirming death by neurological criteria include digital subtraction angiography (DSA), SPECT (absent cerebral perfusion), and EEG (electrocerebral silence). CT brain showing extensive parenchymal damage is not a reliable ancillary test.

Autoimmune, Inflammatory, and Demyelinating CNS Disorders

  • Satralizumab & MOGAD: ((NEUR036)): Satralizumab is an anti-IL-6 pathway monoclonal antibody used in relapsing antibody-mediated demyelinating disease (MOGAD). IL-6 supports B-cell activation, Th17 differentiation, and plasmablast survival. (Distractor: Inebilizumab is an anti-CD19 antibody targeting B-lineage cells used in NMOSD).
  • Childhood Primary CNS Vasculitis (cPACNS): ((NEUR037)): Small-vessel cPACNS presents with subacute focal seizures, cognitive decline, and multifocal inflammatory lesions. Routine inflammatory markers (ESR, CRP) are frequently normal. Von Willebrand factor antigen (vWF-Ag) is an endothelial cell-derived biomarker that correlates with disease activity and helps distinguish small-vessel cPACNS from demyelinating mimics.
  • Childhood Primary CNS Vasculitis (Post-Varicella Arteriopathy): ((NEUR058)): Monophasic inflammatory vasculopathy presenting weeks to months after varicella infection with ischemic stroke or TIA. Angiography shows unilateral irregular proximal MCA stenosis with absence of collateral formation. It tends to improve spontaneously.
  • Complement Deficiencies & Meningococcal Disease: ((NEUR038)): Terminal complement component defects (C5–C8) cause recurrent meningococcal infections, but properdin system defects (alternative pathway C3 convertase stabilizer) carry the highest risk of lethal meningococcal disease.
  • Acute Disseminated Encephalomyelitis (ADEM): ([NEUR048, #NEUR068]): Monophasic demyelinating illness characterized by acute multifocal CNS demyelination with encephalopathy, LETM, and optic pathway lesions. Lesions typically lack contrast enhancement, distinguishing active inflammation from chronic scars.
  • Clinically Isolated Syndrome (CIS): ((NEUR069)): A first clinical demyelinating event showing both Dissemination in Space (DIS) and Dissemination in Time (DIT) (presence of both contrast-enhancing and non-enhancing lesions of varying ages). Can test positive for AQP4-IgG or MOG-Ab. ---

Epilepsies and Epileptic Encephalopathies

  • Cannabidiol (CBD) Indications: ((NEUR042)): FDA-approved for adjunctive treatment of seizures in Dravet syndrome, Lennox-Gastaut syndrome, and Tuberous sclerosis complex. Not approved or effective for Childhood Absence Epilepsy (CAE). Mechanisms include GPR55 inhibition, ENT-1 inhibition (increased adenosine), and TRPV1 desensitization (does not act on CB1/CB2).
  • Ketogenic Diet (KD) Contraindications: ((NEUR043)): Pyruvate carboxylase deficiency is an absolute contraindication to KD due to the inability to convert pyruvate to oxaloacetate, causing life-threatening ketotic acidosis. (In contrast, Pyruvate dehydrogenase (PDH) deficiency is a first-line indication for KD).
  • Jeavons Syndrome (Epilepsy with Eyelid Myoclonia): ((NEUR044)): Defined by the clinical triad: (1) Eyelid myoclonia with/without absence seizures, (2) Eye closure-induced seizures in light, and (3) Photosensitivity. EEG shows generalized polyspike-wave discharges. Axial myoclonia is not a core feature.
  • Succinic Semialdehyde Dehydrogenase (SSADH) Deficiency: ((NEUR045)): Caused by pathogenic variants in ALDH5A1, leading to GABA and 4-hydroxybutyric acid (GHB) accumulation. Features global developmental delay, hypotonia, ataxia, behavioral issues, sleep disturbance, and seizures.
  • Sleep-Related Hypermotor Epilepsy (SHE): ((NEUR046)): Characterized by clusters of brief hypermotor seizures during NREM sleep (bicycling, thrashing) with rapid recovery. Most commonly associated with mutations in CHRNA4 (alpha-4 subunit of neuronal nicotinic acetylcholine receptor).
  • Epilepsy of Infancy with Migrating Focal Seizures (EIMFS): ((NEUR056)): Severe developmental and epileptic encephalopathy beginning in the first 6 months of life. Features multi-focal seizures that "migrate" across brain regions and burst-suppression EEG. Caused by KCNT1 mutations.
  • Landau-Kleffner Syndrome (LKS): ((NEUR054)): Acquired epileptic aphasia presenting in children aged 3–8 years with progressive loss of receptive language, behavioral changes, and sleep-activated continuous spike-and-wave discharges predominantly in the temporal regions.
  • Status Epilepticus Management: ((NEUR064)): Sequential steps: (1) First-line: Benzodiazepines (lorazepam/diazepam); (2) Second-line (refractory after 2 doses of benzos): IV non-sedating antiseizure medications phenytoin, valproate, or levetiracetam; (3) Third-line: Continuous anesthetic infusions (midazolam, propofol, thiopental).
  • Antiseizure Medication Hypersensitivity: ((NEUR065)): Aromatic ASMs (phenytoin, carbamazepine, phenobarbital, lamotrigine) share structural cross-reactivity and can trigger severe cutaneous adverse reactions like Stevens-Johnson syndrome (SJS). Levetiracetam has a low risk of hypersensitivity and no cross-reactivity, making it a safe alternative. ---

Leukodystrophies, Lysosomal Storage, and Metabolic Disorders

  • Canavan Disease: ((NEUR049)): Autosomal recessive leukodystrophy caused by ASPA gene mutations (aspartoacylase deficiency), causing toxic accumulation of N-acetylaspartic acid (NAA). Features macrocephaly, developmental delay, hypotonia, and diffuse subcortical white matter signal changes with sparing of the corpus callosum and bilateral globus pallidus involvement.
  • Pelizaeus–Merzbacher Disease (PMD): ((NEUR051)): X-linked leukodystrophy caused by PLP1 mutations. Presents in early infancy with nystagmus, hypotonia, progressive spasticity, and diffuse cerebral hypomyelination (failure of myelin formation rather than destruction).
  • Adrenoleukodystrophy (ALD): ((NEUR059)): X-linked peroxisomal disorder caused by ABCD1 mutations leading to accumulation of very long-chain fatty acids (VLCFAs). Triad of declining school performance, behavioral changes, and adrenal insufficiency (hypertrophy/darkening skin).
  • Vanishing White Matter Disease (VWMD): ((NEUR055)): Caused by mutations in EIF2B5 (or other EIF2B genes). Characterized by episodic neurological regression and ataxia triggered by minor febrile illnesses. MRI shows diffuse bilateral symmetrical white matter rarefaction with CSF-like signal intensity. Optic atrophy is typically absent.
  • Fabry Disease: ((NEUR052)): X-linked lysosomal storage disorder caused by $\alpha$-galactosidase A deficiency, leading to globotriaosylceramide accumulation. Features acroparesthesias (severe burning pain in hands/feet triggered by heat/exercise), hypohidrosis, angiokeratomas ("bathing suit" distribution), cornea verticillata (whorl-like corneal opacities), and early renal failure.
  • GM1 Gangliosidosis: ((NEUR066)): Infantile lysosomal storage disorder due to $\beta$-galactosidase deficiency (GLB1). Features developmental regression, hypotonia, coarse facial features, hepatosplenomegaly, macular cherry-red spot, and dysostosis multiplex on skeletal X-rays.
  • Cerebral Creatine Deficiency Syndromes (CCDS): ((NEUR060)): Creatine transporter deficiency (CRTR, encoded by SLC6A8 on X-chromosome) presents with global developmental delay, autistic features, microcephaly, seizures, and a markedly increased urinary creatine:creatinine ratio.
  • Alpers-Huttenlocher Syndrome: ((NEUR061)): Mitochondrial DNA depletion disorder due to recessive POLG1 mutations. Classic triad: refractory epilepsy, developmental regression, and liver failure. Valproate is strictly CONTRAINDICATED as it triggers fatal hepatotoxicity.
  • Glucose Transporter 1 Deficiency Syndrome (Glut1DS): ((NEUR057)): Caused by SLC2A1 mutations impairing glucose transport across the blood-brain barrier. Features infantile seizures, developmental delay, acquired microcephaly, and paroxysmal movement disorders. Diagnosis supported by low CSF glucose with a decreased CSF-to-blood glucose ratio. Ketogenic diet is the first-line treatment. Valproate and phenobarbital are ineffective and not recommended.
  • Pyridoxine-Dependent Epilepsy (PDE): ((NEUR067)): Caused by ALDH7A1 (antiquitin) mutations. Presents in neonates with intractable seizures refractory to standard ASMs, but dramatically responsive to pyridoxine (vitamin B6). ---

Neurogenetic, Paraneoplastic, and Movement Disorders

  • Aicardi–Gouttières Syndrome (AGS): ((NEUR053)): Type I interferonopathy caused by mutations in nucleic acid metabolism genes. Mimics congenital infection with early neuroregression, intracranial calcifications (basal ganglia/periventricular), CSF lymphocytic pleocytosis with elevated interferon-$\alpha$, and chilblain-like skin lesions on fingers, toes, and ears. Treated investigationally with Janus kinase (JAK) inhibitors.
  • Cockayne Syndrome: ((NEUR050)): Autosomal recessive disorder of nucleotide excision repair (ERCC6/CSB or ERCC8/CSA). Features neurodegeneration, growth failure, ataxia, sensorineural hearing loss, basal ganglia calcifications, and extreme photosensitivity (severe sunburns with minimal sun exposure).
  • Opsoclonus-Myoclonus-Ataxia Syndrome (OMAS): ((NEUR062)): Immune-mediated paraneoplastic disorder associated with neuroblastoma. Characterized by opsoclonus (rapid chaotic eye movements), myoclonus, and ataxia, alongside extreme irritability and sleep disturbances. MRI or CT with contrast of the thorax and abdomen has the highest sensitivity for finding the occult tumor.
  • Myoclonus-Dystonia Syndrome (DYT11): ((NEUR063)): Autosomal dominant movement disorder caused by SGCE mutations with paternal imprinting. Characterized by myoclonic jerks (neck, trunk, upper limbs) combined with focal dystonia (torticollis, writer's cramp). Cognition is normal.
  • Familial Hemiplegic Migraine Type 1 (FHM1): ((NEUR047)): Caused by CACNA1A mutations (P/Q-type calcium channel). Features recurrent attacks of transient hemiplegia, aphasia, and migraine headaches, occasionally triggered by minor head trauma.
  • Rett Syndrome: ((NEUR070)): X-linked dominant neurodegenerative disorder caused by MECP2 mutations. Presents with deceleration of head growth, loss of purposeful hand use with stereotypic wringing, gait ataxia, and autonomic breathing abnormalities (hyperventilation/breath-holding). Trofinetide is an FDA-approved synthetic analog of IGF-1 that promotes synaptic maturation. ---

Miscellaneous Infectious & Neuroimaging Conditions

  • Tick-Borne Encephalitis Virus (TBEV): ((NEUR040)): Transmitted by ticks or via consumption of unpasteurized dairy products from endemic rural areas, even without a recognized tick bite.
  • Haemophilus influenzae Serotypes: ((NEUR039)): H. influenzae type b (Hib) is the classic cause of invasive meningitis in unimmunized children, alongside non-b serotypes a and f. Type d is not classically associated with invasive disease.
  • Idiopathic Intracranial Hypertension (IIH) Imaging Signs: ((NEUR041)): In the absence of papilledema or 6th nerve palsy, IIH diagnosis requires elevated opening pressure and at least three of four neuroimaging signs: (1) Empty sella, (2) Flattening of the posterior globe, (3) Distention of the perioptic subarachnoid space, and (4) Transverse venous sinus stenosis. Optic nerve contrast enhancement is absent in IIH.

Movement Disorders & Channelopathies

  • Paroxysmal Kinesigenic Dyskinesia (PKD): ((NEUR071)): Characterized by brief seconds-long episodes of dystonia/chorea triggered by sudden movement starting in childhood/adolescence, with a strong family history. Caused by mutations in the PRRT2 gene (proline-rich transmembrane protein 2). Treatment of choice includes sodium channel blockers (carbamazepine, phenytoin). Distractor note: GLUT1 mutations cause GLUT1 deficiency syndrome (exercise-induced dyskinesias/seizures).
  • Hyperekplexia (Stiff Baby Syndrome): ((NEUR091)): Neonatal-onset generalized stiffness, life-threatening tonic spasms with apnea, and exaggerated startle triggered by auditory/tactile stimuli with a nonfatigable head retraction reflex upon nasal tapping. Treatment of choice is clonazepam; acute episodes can be aborted via the Vigevano maneuver (repeated neck and hip flexion).
  • Tardive Dyskinesia: ((NEUR096)): Delayed-onset involuntary movement disorder appearing after \>3 months of chronic dopamine-blocking medication exposure (e.g., risperidone), classically presenting with stereotyped orofacial movements (lip-smacking, chewing, tongue-thrusting). Distractor note: Acute dystonic reactions occur within days of exposure and feature painful muscle spasms like torticollis.
  • Cervical Dystonia: ((NEUR097)): Focal dystonia causing abnormal head/neck posturing worsened by specific tasks and temporarily alleviated by a sensory trick (e.g., touching the chin). When levodopa-responsive dystonia is ruled out via a negative levodopa-carbidopa trial, botulinum toxin injections are the first-line targeted therapy for focal presentations.

Cranial Nerves & Neuro-Ophthalmology

  • Trochlear Nerve (CN IV) Palsy: ((NEUR072)): Weakness of the superior oblique muscle, presenting with vertical/oblique diplopia that worsens during reading or walking downstairs. Patients adopt a compensatory head tilt away from the affected side.
  • Internuclear Ophthalmoplegia (INO): ((NEUR073)): Caused by a lesion of the medial longitudinal fasciculus (MLF). Presents with impaired adduction of the eye on the side of the lesion and abduction-induced nystagmus in the contralateral eye during horizontal gaze, with preserved convergence (proving intact medial rectus/CN III subnucleus function). Note: The side of the lesion corresponds to the side of the impaired adduction.

Malformations & Syndromic Neurodevelopmental Disorders

  • Meckel-Gruber Syndrome: ((NEUR078)): Autosomal recessive ciliopathy featuring the triad of occipital encephalocele, polycystic kidneys, and postaxial polydactyly, along with cleft palate and microphthalmia ((NEUR074)).
  • Aicardi Syndrome: ((NEUR076)): X-linked dominant condition almost exclusively affecting females, characterized by resistant infantile spasms, agenesis of the corpus callosum, chorioretinal lacunae, and periventricular nodular heterotopia. Vertebral anomalies such as hemivertebrae are frequently associated.
  • Pfeiffer Syndrome: ((NEUR077)): Syndromic craniosynostosis linked to FGFR1/FGFR2 mutations, distinguished by midface hypoplasia, shallow orbits with proptosis, and broad thumbs and great toes.
  • PHACE Syndrome: ((((NEUR075)) · ((NEUR095)))): Association of posterior fossa malformations, segmental hemangiomas of the face/scalp, arterial anomalies, coarctation of the aorta, and eye anomalies. The acronym expands to PHACES when ventral developmental defects like sternal clefting or supraumbilical raphe are present.

Pediatric Epilepsy Syndromes & Management

  • Febrile Seizure Lumbar Puncture Guidelines: ((NEUR078)): Lumbar puncture is an option (not mandatory) in a 6–12-month-old child with a simple febrile seizure if Haemophilus influenzae type b or Streptococcus pneumoniae vaccination status is deficient or unknown.
  • Panayiotopoulos Syndrome: ((NEUR079)): Benign early childhood focal epilepsy characterized by nocturnal focal seizures with prominent autonomic symptoms (especially ictal vomiting)**, pallor, and occipital spikes on EEG. Self-limited and outgrown within years.
  • Self-Limited (Benign) Epilepsy with Centrotemporal Spikes (BECTS): ((NEUR080)): Children aged 3–10 years presenting with sleep-related focal seizures, preserved awareness, unilateral facial clonic movements (corner of mouth), and high-amplitude centrotemporal spikes. Oxcarbazepine or carbamazepine is indicated for frequent/generalized seizures.
  • Early Myoclonic Encephalopathy (EME): ((NEUR081)): Presents in the first 2 months of life with severe myoclonic seizures and an EEG burst-suppression pattern, heavily linked to inborn errors of metabolism such as nonketotic hyperglycinemia (distinguishing it from Ohtahara syndrome, which features tonic seizures and structural brain malformations).
  • Hyperinsulinism-Hyperammonemia Syndrome: ((NEUR083)): Caused by gain-of-function variants in the **GLUD1 gene**, presenting with postprandial hypoglycemic seizures (following protein-rich foods like eggs/meat) and persistent moderate hyperammonemia (80–150 µmol/L) with normal liver function tests.
  • Epilepsy Sports Guidance - Skydiving: ((NEUR084)): Skydiving falls under Group 3 high-risk sports. For children with sleep-related seizures, participation in Group 2 and Group 3 sports is at neurologist’s discretion.
  • Fenfluramine in Lennox-Gastaut Syndrome: ((NEUR085)): Approved for drop attacks in Lennox-Gastaut syndrome, available exclusively via a restricted distribution REMS program due to risks of valvular heart disease and pulmonary arterial hypertension.
  • Rufinamide and Cardiac Electrophysiology: ((NEUR086)): Rufinamide can shorten the QT interval and is strictly contraindicated in familial short QT syndrome.
  • GRIN2A-Related Genetic Epilepsy: ((NEUR087)): Gain-of-function variants in GRIN2A cause focal epilepsies with language regression (e.g., Landau-Kleffner spectrum), treatable with NMDA receptor antagonists such as dextromethorphan or memantine.
  • Self-Limited Neonatal Seizures ("Fifth-Day Fits"): ((NEUR088)): Onset on days 4–6 of life with frequent clusters of unilateral/bilateral clonic jerks, normal workup, and spontaneous resolution within 48 hours.
  • FIRES (Febrile Infection-Related Epilepsy Syndrome): ((NEUR090)): A subtype of NORSE presenting as sudden-onset refractory status epilepticus in previously healthy children 1–14 days after a febrile illness. Early recommended therapy includes ketogenic diet and anakinra (IL-1 receptor antagonist).

Neuro-Metabolic & Systemic Mimics

  • Sulfite Oxidase / Molybdenum Cofactor Deficiency: ((NEUR089)): Neonatal seizures and MRS showing increased lactate, myoinositol, and choline with decreased NAA, mimicking hypoxic-ischemic encephalopathy without a hypoxic history. Diagnosed via plasma homocysteine, uric acid, and urine sulfites/sulfocysteine.
  • ROHHAD Syndrome: ((NEUR100)): Rapid-onset obesity, hypothalamic dysfunction, hypoventilation, and autonomic dysregulation with normal brain MRI. Mandatory screening is required for neural crest tumors (neuroblastoma).
  • Basal Ganglia Encephalitis: ((NEUR101)): Associated with anti-D2R antibodies, presenting with lethargy, abnormal movements, agitation, psychosis, and basal ganglia T2/FLAIR hyperintensities.
  • Pediatric Multiple Sclerosis Therapy: ((NEUR102)): Fingolimod is an FDA-approved oral disease-modifying therapy for pediatric-onset relapsing-remitting multiple sclerosis, demonstrating high efficacy in reducing annualized relapse rates.
  • Subacute Combined Degeneration: ((NEUR103)): Vitamin B12 deficiency presenting with dorsal column and pyramidal tract dysfunction. MRI spine demonstrates T2-hyperintensity in the posterior columns forming an "inverted V" or "inverted rabbit ear" sign. Note: Hematologic abnormalities are absent in up to 30% of neurologic cases.
  • Fabry Disease: ((NEUR104)): X-linked lysosomal storage disorder (alpha-galactosidase A deficiency) causing posterior circulation strokes/TIAs, episodes of burning distal extremity pain ("growing pains") exacerbated by fever/exercise, hypohidrosis (heat intolerance), angiokeratomas over the lower trunk/groin, and early proteinuria.

Neuroinfections & Headaches

  • Acute Bacterial Meningitis & Sepsis: ((NEUR105)): Overwhelming meningococcal sepsis can present with completely absent CSF leukocytosis (no pleocytosis) due to leukocyte consumption/sequestration; this is a poor prognostic sign and does not rule out bacterial meningitis.
  • Pediatric Migraine Aura vs. Mimics: ((NEUR092)): Transient visual blurring occurring after the headache is already severe does not constitute an aura (which must precede the headache and spread gradually). Migraine without aura can present with bilateral/frontotemporal pulsating pain lasting 2–72 hours in children.
  • Headache Red Flags in Young Children: ((NEUR093)): Children <6 years old cannot reliably characterize headaches; thus, new recurrent headaches in this age group mandate neuroimaging regardless of a normal neurological exam.
  • Status Migrainosus Emergency Management: ((NEUR094)): Acute abortive strategies include antidopaminergics (prochlorperazine), NSAIDs (ketorolac), and vasoconstrictors (dihydroergotamine). Propranolol is strictly for prophylaxis and has no role in acute emergency treatment.

Infections & Prophylaxis

  • Meningeal and *Haemophilus* Chemoprophylaxis: ((NEUR106)): Rifampin is indicated for chemoprophylaxis in both invasive Haemophilus influenzae type b disease and meningococcal disease. For meningococcal exposure, close contacts $>1\text{ month}$ old receive 15–20 mg/kg/dose every 12 hours for 2 days.

Encephalopathies & Infectious Syndromes

  • Mild Encephalopathy with Reversible Splenial Lesion (MERS): ((NEUR107)): Characterized by an isolated reversible lesion in the splenium of the corpus callosum during an acute febrile illness with mild drowsiness and confusion, frequently associated with Respiratory syncytial virus (RSV), rotavirus, influenza, adenovirus, and Salmonella.
  • Acute Necrotizing Encephalopathy of Childhood (ANEC): ((NEUR112)): Fulminant post-viral encephalopathy (typically influenza, parainfluenza, or dengue) presenting with rapid progression to coma within 24 hours, seizures, and decerebrate posturing. CSF reveals mildly raised protein with no pleocytosis. MRI demonstrates characteristic symmetric multi-focal lesions involving the thalami, brainstem, and cerebral white matter.

Parasitic Infections

  • Neurognathostomiasis: ((NEUR108)): Acquired via ingestion of raw/undercooked freshwater fish or frogs containing Gnathostoma spinigerum larvae (endemic in Southeast Asia/Thailand). Presents with severe headache, neck stiffness, radicular pain, and asymmetric lower-limb weakness. CSF shows eosinophilic pleocytosis, xanthochromia, and elevated protein with normal glucose; MRI demonstrates patchy radiculomyelitis with small hemorrhagic tracts.

Neurodegeneration with Brain Iron Accumulation & Lysosomal Storage Disorders

  • Pantothenate Kinase-Associated Neurodegeneration (PKAN): ((NEUR109)): Caused by PANK2 gene mutations (autosomal recessive). Characterized by progressive extrapyramidal symptoms (rigidity, dystonia), bulbar dysfunction, pigmentary retinopathy, and cognitive regression. Pathognomonic MRI finding is the “Eye of the Tiger” sign (T2 hypointensity in the globus pallidus with central hyperintensity).
  • Infantile Neuronal Ceroid Lipofuscinosis (CLN1): ((NEUR111)): Caused by PPT1 deficiency (autosomal recessive). Presents within the first year of life (normal until 10 months) with neuroregression, myoclonic jerks, seizures, microcephaly, optic atrophy, and spasticity. EEG reveals a burst-suppression pattern, and electron microscopy of lymphocytes demonstrates osmiophilic cytoplasmic granules.
  • Metachromatic Leukodystrophy (MLD): ((NEUR113)): Lysosomal storage disorder due to arylsulfatase A deficiency leading to sulfatide accumulation. Features motor regression, spasticity, and optic atrophy. MRI demonstrates symmetrical periventricular white matter T2 hyperintensities with sparing of subcortical U-fibers and a classic tigroid pattern (alternating stripes of demyelination and perivenular sparing).
  • Sialidosis Type I (Cherry-Red Spot Myoclonus Syndrome): ((NEUR128)): Presents in the second decade with progressive visual deterioration, a cherry-red spot on fundoscopy, and severe progressive myoclonus triggered by voluntary movement, touch, and sound. Myoclonus is notoriously refractory to anticonvulsants, whereas generalized convulsions respond well.

Metabolic & Kernicterus Syndromes

  • Wilson Disease: ((NEUR117)): Autosomal recessive disorder of copper metabolism caused by ATP7B mutations on chromosome 13, impairing biliary copper excretion and ceruloplasmin incorporation. Manifests with neurologic (dystonia, tremor, dysarthria, parkinsonism), psychiatric, and hepatic dysfunction. Associated with Kayser-Fleischer rings on slit-lamp examination and basal ganglia T2/FLAIR hyperintensities.
  • Kernicterus / Bilirubin Encephalopathy: ((NEUR118)): Sequela of severe neonatal hyperbilirubinemia requiring exchange transfusion, characterized by extrapyramidal movement disorders (dystonia, choreoathetosis). Unconjugated bilirubin preferentially targets and damages the globus pallidus, subthalamic nucleus, and specific cranial nerve nuclei.
  • Glutaric Aciduria Type 1 (GA-1): ((NEUR121)): Autosomal recessive deficiency of glutaryl-CoA dehydrogenase leading to glutaric acid accumulation. Presents in infancy with macrocephaly and acute dystonia. MRI demonstrates characteristic frontotemporal atrophy with widened Sylvian fissures (“bat-wing” appearance) and subdural hematomas.
  • Biotin-Thiamine-Responsive Basal Ganglia Disease (BTBGD): ((NEUR122)): Autosomal recessive disorder caused by SLC19A3 mutations (thiamine transporter). Presents with recurrent acute encephalopathy, dystonia, and seizures triggered by febrile illness. MRI shows bilateral symmetric hyperintensity and swelling in the caudate nucleus and putamen with sparing of the globus pallidus. Treatment is high-dose thiamine and biotin.

Epileptic Encephalopathies & Epilepsies

  • Infantile Epileptic Spasms Syndrome (IESS / West Syndrome): ((NEUR110)): Characterized by clusters of sudden, brief flexor/extensor spasms, developmental arrest or regression, and a chaotic EEG pattern of hypsarrhythmia (high-voltage slow waves with multifocal spikes and sharp waves). First-line therapy includes ACTH, corticosteroids, or vigabatrin.
  • Childhood Absence Epilepsy (CAE): ((NEUR116)): Idiopathic generalized epilepsy presenting between ages 4–10 years with brief, frequent staring spells (10–20 seconds) with immediate recovery and no postictal confusion, easily provoked by hyperventilation. Hallmark EEG shows generalized, symmetric 3 Hz spike-and-wave discharges.

Neurocutaneous & Malformation Syndromes

  • Sturge-Weber Syndrome: ((NEUR115)): Congenital phakomatosis characterized by a facial port-wine stain in the V1 trigeminal distribution and an ipsilateral leptomeningeal angioma. Noncontrast CT reveals pathognomonic gyriform "tram-track" cortical calcifications overlying an atrophic cortex.
  • Schizencephaly: ((NEUR114)): Congenital neuronal migration disorder characterized by a CSF-filled cleft extending from the ependyma to the pial surface, lined by heterotopic gray matter (distinguishing it from acquired porencephalic cysts).
  • Craniopharyngioma: ((NEUR119)): Most common suprasellar pediatric brain tumor arising from Rathke's pouch remnants. Presents with features of raised ICP, endocrine deficits (short stature, delayed puberty, diabetes insipidus), and bitemporal hemianopia. CT typically demonstrates a mixed solid-cystic mass with coarse calcifications.
  • Joubert Syndrome: ((NEUR120)): Autosomal recessive disorder presenting with hypotonia, ataxia, and abnormal breathing. Brain MRI shows the pathognomonic "molar tooth sign", caused by cerebellar vermis hypoplasia, a deepened interpeduncular fossa, and thickened, elongated superior cerebellar peduncles (inferior cerebellar peduncles are not thickened).
  • Focal Cortical Dysplasia (FCD): ((NEUR125)): Localized malformation of cortical development representing a leading cause of drug-resistant focal epilepsy in children, requiring presurgical MRI evaluation to identify subtle localized dysplastic cortex.
  • Chiari Type I Malformation: ((NEUR126)): Downward displacement of cerebellar tonsils below the foramen magnum, classically presenting in late childhood or adolescence with occipital or suboccipital headaches worsening with coughing, straining, or Valsalva maneuvers, alongside neck pain and long-tract signs.
  • Neurofibromatosis Type 1 (NF1): ((NEUR127)): Diagnosed clinically by criteria including café-au-lait spots, axillary/inguinal freckling, Lisch nodules, and neurofibromas. Associated with increased incidence of pheochromocytoma, rhabdomyosarcoma, leukemia, and Wilms tumor, but not medulloblastoma.

Vascular & Demyelinating Disorders

  • Neuromyelitis Optica Spectrum Disorder (NMOSD) & Longitudinally Extensive Transverse Myelitis (LETM): ((NEUR129)): Acute transverse myelitis extending over $\ge 3$ contiguous vertebral segments. Serum AQP4-IgG positivity strongly shifts the diagnosis away from pediatric multiple sclerosis toward NMOSD.
  • Moyamoya Syndrome: ((NEUR130)): Characterized by progressive distal internal carotid artery occlusion and a prominent basal collateral vascular network ("puff of smoke"). Associated with sickle cell anemia, neurofibromatosis type 1, trisomy 21, Williams syndrome, and radiation, but not tuberous sclerosis complex.
  • Cerebral Sinovenous Thrombosis (CSVT): ((NEUR131)): Often secondary to contiguous infections like mastoiditis. In pediatric CSVT, the presence of a small hemorrhagic venous infarct is not an absolute contraindication to anticoagulation, which should be initiated alongside infection control.

Spinal Dysraphism & Orthopedic Neuromuscular Associations

  • Tethered Cord Syndrome: ((NEUR132)): Causes neuroorthopedic foot changes (small, high-arched foot with clawing toes, calf atrophy, absent ankle reflex) and lower urinary tract symptoms (increasing urinary urgency) due to abnormal traction on the conus medullaris.
  • Diastematomyelia (Split-Cord Malformation): ((NEUR133)): Congenital spinal anomaly where the spinal cord is split into two hemicords (contained within a single dural tube in Type 2, or separate dural tubes separated by an osseocartilaginous septum in Type 1), frequently associated with lower-limb asymmetry and scoliosis.

Neonatal & Pediatric Neurological Examination Fundamentals

  • Developmental Milestone Assessment (19-Month-Old): ((NEUR134)): At 18–19 months, normal milestones include walking upstairs with assistance (gross motor), feeding with a spoon (fine motor), imitating parental actions (social), and speaking at least six meaningful words (language). Failure in a single domain (e.g., self-feeding) indicates an isolated fine motor delay.
  • Muscle Tone Pathophysiology: ((NEUR135)): Extrapyramidal lesions produce rigidity (uniform, velocity-independent resistance affecting agonist and antagonist muscles equally, predominantly axial/proximal), whereas pyramidal tract lesions produce spasticity (velocity-dependent resistance).
  • Somatosensory Pathways: ((NEUR136)): The dorsal column–medial lemniscus (DCML) pathway transmits joint position, vibration, barognosis, stereognosis, and discriminative touch. Crude touch is transmitted via the anterior spinothalamic tract.
  • Neonatal Neurological Assessment State: ((NEUR137)): Preterm infants born at $<28$ weeks' gestation lack consistent alertness due to immature sleep-wake organization; variability in arousal is a normal physiological variation rather than a sign of cerebral dysfunction.
  • Head Circumference Measurement: ((NEUR138)): Must be measured using a non-distensible tape placed over the mid-forehead and across the most prominent part of the occiput to capture the maximum occipitofrontal circumference.
  • Infant Head Growth Velocity: ((NEUR139)): Normal head circumference is $\sim 34\text{--}35\text{ cm}$ at birth, increases by $\sim 2\text{ cm/month}$ (first 3 months), and reaches approximately 43–44 cm at 6 months of age.
  • Macrocephaly and Skull Morphology: ((NEUR140)): Chronic subdural hemorrhage in infants causes progressive extra-axial fluid accumulation that expands the middle cranial fossa, producing a characteristic broad, squared, or box-like skull configuration.

Neonatal Skull Findings and Fontanels

  • Positional Plagiocephaly: ((NEUR141)): Unilateral flattening of the occiput with normal head circumference and no focal deficits. Most prominent in hypotonic or weak infants due to reduced spontaneous movement and persistent positioning on one side. Differentiated from craniosynostosis by preserved suture mobility and association with decreased motility rather than premature suture fusion.
  • Anterior Fontanel Closure: ((NEUR142)): Normal size is ~2×2 cm at birth. Average closure is at 18 months, but closure as early as 9 months is a normal physiological variant. An absent or very small anterior fontanel at birth raises concern for craniosynostosis or microcephaly ((NEUR146)).
  • Anterior Fontanel Examination Technique: ((((NEUR143)) · ((NEUR145)))): Best assessed while the infant is held upright during sleep or feeding (calm and relaxed state), where it normally feels slightly depressed and pulsatile. Vigorous crying transiently increases intracranial venous pressure, making the fontanel falsely appear tense or bulging; reassessment while calm is mandatory before diagnosing pathology.
  • Persistent Posterior Fontanel: ((NEUR144)): Normally closed at birth or admits a fingertip, closing completely within 6–8 weeks. Persistence beyond this window is abnormal and most commonly points to congenital hypothyroidism or hydrocephalus.
  • Scalp Vein Distention: ((NEUR147)): Marked venous prominence without skin inflammation is an abnormal finding indicating either raised intracranial pressure or superior sagittal sinus thrombosis.
  • Physiological Cranial Bruits: ((NEUR148)): Soft, symmetrical bruits heard over the anterior fontanel and temporal regions can be a normal variant in children younger than 4 years or during febrile states. Loud or localized bruits are pathological, pointing to arteriovenous malformations (e.g., vein of Galen malformation), severe anemia, or high ICP.
  • Cranial Suture Overriding: ((NEUR149)): Mild molding is a normal consequence of vaginal delivery. Marked overriding persisting beyond the early neonatal period is abnormal and suggests an underlying brain abnormality. Distinct from craniosynostosis, which presents with palpable bony ridges rather than overriding.

Cranial Nerve Examination: Olfactory to Trigeminal

  • Olfactory Nerve (CN I) Bedside Testing: ((((NEUR150)) · ((NEUR151)) · ((NEUR152)) · ((NEUR153)))): Test using non-irritating, familiar substances like coffee or peppermint (avoiding trigeminal-stimulating irritants like ammonia). Reliable bedside assessment is possible starting at 32 weeks’ gestation (evaluating alerting/withdrawal responses). Test each nostril separately by occluding the contralateral side; failure to identify an odor when the opposite nostril is occluded indicates contralateral/isolated olfactory dysfunction of the open nostril's side (((NEUR152)) · ((NEUR153))).

Cranial Nerve Examination: Visual System and Fundus

  • Neonatal Optic Disc: ((NEUR154)): A gray-white optic disc in a newborn (especially in fair-complexioned infants) can be a physiological variant and should not be misdiagnosed as optic atrophy (which features salmon-pink to normal adult coloring in older children).
  • Papilledema vs. Disc Edema: ((((NEUR155)) · ((NEUR156)))): Disc edema is a general term; papilledema specifically refers to disc swelling caused by raised intracranial pressure. Early papilledema classically presents with an enlarged blind spot with preserved visual acuity and color vision, differentiating it from optic neuritis (which exhibits early loss of visual acuity and impaired color vision).
  • Neonatal Retinal Hemorrhages: ((NEUR157)): Present in 30–40% of full-term vaginal deliveries as a physiological finding, but they spontaneously resolve within 1–2 weeks. Retinal hemorrhages persisting beyond this window raise high concern for nonaccidental trauma.
  • Pupillary Light Reflex in Prematurity: ((NEUR158)): Detectable by 29–32 weeks' corrected gestational age, but difficult to assess due to technical challenges (infants tightly resisting eye opening and having poorly pigmented irises).

Ocular Movements and Brainstem Reflexes

  • Ocular Bobbing: ((NEUR159)): Characterized by rapid conjugate downward jerks followed by a slow return to primary position. Classic localizing sign for pontine dysfunction/lesions.
  • Oculocephalic Reflex (Doll's Eye): ((NEUR160)): Tests brainstem vestibulo-ocular integrity in comatose patients. Conjugate eye deviation opposite to head rotation confirms intact brainstem pathways (involving vestibular nuclei, MLF, and CN III, IV, VI).
  • Physiological Strabismus: ((NEUR161)): Infants <2 months can exhibit a normal horizontal dysconjugate gaze of 1–2 mm at rest due to immature extraocular motor control.
  • Corneal Reflex: ((NEUR162)): Tests the afferent limb via the ophthalmic division of the trigeminal nerve (CN V1) and the efferent limb via the facial nerve (CN VII). Absence signifies a lesion in either or both nerves.
  • Nasal Tickle Test: ((NEUR163)): Useful bedside test for sensory trigeminal nerve (CN V) function in uncooperative or comatose patients (cotton swab stimulation elicits a symmetrical grimace).

Cranial Nerve Examination: Facial, Vestibulocochlear, and Lower CNs

  • Facial Nerve (CN VII) Palsy Localization: ((NEUR164)): Lower motor neuron (LMN) lesions (e.g., Bell palsy, injury to the nerve) cause weakness of both upper and lower face on the affected side (inability to close eye, sagging mouth, forehead involvement). Upper motor neuron (UMN) lesions (cortical strokes) spare forehead wrinkling and eye closure due to bilateral cortical innervation of the upper face.
  • Vestibular Nerve Dysfunction & Caloric Testing: ((((NEUR165)) · ((NETU166)) · ((NEUR167)))): Unilateral vestibular lesions cause postural drift, Fukuda stepping deviation, and falling toward the side of the lesion. Spontaneous jerk nystagmus beats away from the lesion (fast phase). Caloric testing uses 2 mL of ice water in awake, alert patients (to minimize nausea) versus 30–50 mL in comatose patients.
  • Newborn Hearing Screening: ((((NEUR168)) · ((NEUR169)) · ((NEUR170)))): Universal hearing screening must be completed within the first month of life. Newborns initially respond to loud sounds with motor cessation/eye opening and exhibit habituation (diminishing response with repeated identical stimuli). True sound localization emerges at 3–4 months.
  • Vagus Nerve (CN X) Anatomy & Lesions: ((((NEUR171)) · ((NEUR172)) · ((NEUR173)))): Supplies motor innervation to all pharyngeal and laryngeal muscles except two: the stylopharyngeus (supplied by CN IX) and the tensor veli palatini (supplied by the mandibular branch of CN V3). Unilateral vagus lesions cause ipsilateral palatal weakness and hoarseness.
  • Accessory Nerve (CN XI) Injury: ((NEUR174)): Innervates the sternocleidomastoid (SCM) and trapezius. Unilateral injury causes ipsilateral shoulder depression (trapezius weakness) and weakness turning the head against resistance away from the side of the lesion.
  • Hypoglossal Nerve (CN XII) Dysfunction: ((NEUR175)): Innervates tongue muscles. Infantile hypoglossal weakness and fasciculations are classically associated with Werdnig-Hoffmann disease (spinal muscular atrophy type 1).

Ocular & Visual Pathway Examination

  • Extraocular Muscle Testing (Superior Oblique): ((NEUR176)): The superior oblique is the primary depressor of the adducted eye, along with abduction and intorsion. Failure of the right eye to depress when adducted indicates right superior oblique dysfunction. - Distractors: The inferior rectus primarily depresses the abducted eye; the inferior rectus and inferior rectus/oblique govern other axes.
  • Visual Fields & Pathways: ((((NEUR177)) · ((NEUR178)))): - Confrontation visual field testing compares the patient's visual field directly with the examiner's with one eye occluded to identify peripheral defects ((NEUR177)). - A right homonymous hemianopia (loss of the right temporal field of the right eye and right nasal field of the left eye) localizes to a post-chiasmal lesion, specifically the left optic tract ((NEUR178)). Optic tract lesions produce incongruous homonymous defects, whereas post-lateral geniculate body lesions produce more congruous defects. ---

Cranial Nerve Lesions

  • Proximal Facial Nerve vs. Distal Lesions: ((NEUR179)): A lesion at the geniculate ganglion or proximal facial nerve causes lower motor neuron facial paralysis plus reduced lacrimation (greater petrosal nerve), impaired salivation, hyperacusis (nerve to stapedius), and loss of taste over the anterior 2/3 of the tongue (chorda tympani). - Distractors: A lesion at the stylomastoid foramen causes facial muscle weakness only, sparing taste, lacrimation, salivation, and stapedius function.
  • Trigeminal Nerve (V3) and Pterygoid Muscle Function: ((((NEUR182)) · ((NEUR183)))): - The mandibular division ($V_3$) carries all motor fibers to muscles of mastication. Unilateral $V_3$ lesions cause masseter/temporalis wasting and jaw deviation toward the lesion site during mouth opening due to unopposed action of the contralateral lateral pterygoid ((NEUR182)). - Weakness of the right lateral pterygoid causes the jaw to deviate to the right upon opening because the intact contralateral muscle acts unopposed ((NEUR183)). Jaw closure is spared as it is mediated by the masseter, temporalis, and medial pterygoids. ---

Neuro-Otology & Auditory Testing

  • Weber Test Lateralization: ((NEUR180)): The Weber test places a vibrating tuning fork on the midline skull. Sound lateralizes to the affected ear in conductive hearing loss and to the normal ear in sensorineural hearing loss. - Distractors: Left conductive hearing loss causes lateralization to the left, making it the least likely explanation for right-sided lateralization. Bilateral symmetrical hearing produces equal sound distribution without lateralization. ---

Higher Cortical Functions & Cognitive Testing

  • Gaze and Saccadic Disorders: ((NEUR181)): Oculomotor apraxia (specifically congenital ocular motor apraxia) features an inability to initiate voluntary saccadic eye movements. Patients compensate via rapid head thrusts to bring targets into view before refixating.
  • Memory Assessment: ((((NEUR181)) · ((NEUR184)) · ((NEUR185)))): - Recent Memory: Assessed by registering and subsequently recalling three unrelated objects after a short interval, minimizing language/executive confounders ((NEUR184)). - Attention & Working Memory: Assessed via the digit span forward test (repeating progressively longer digit sequences in the same order) ((NEUR185)). Digit span backward demands greater executive manipulation.
  • Disorders of Consciousness: ((NEUR186)): Akinetic mutism features preserved sleep-wake cycles, normal brainstem reflexes, and spontaneous respiration, but patients are awake with a profound lack of spontaneous speech and voluntary movement despite limited awareness. - Distractors: Vegetative state features no awareness; minimally conscious state shows inconsistent, minimal definite awareness; locked-in syndrome features preserved full awareness with quadriplegia and bulbar paralysis.
  • Visuoconstructive & Executive Function Tests: ([NEUR187, __NEUR188__, __NEUR189__]): - Clock-Drawing Test: Assesses constructional praxis (parietal lobe function), evaluating visuospatial perception and motor planning ((NEUR187)). - Stroop Color-Word Test: Assesses response inhibition and cognitive flexibility (frontal lobe / prefrontal cortex) ((NEUR188)). - Trail Making Test (Alternating numbers and letters): Assesses set-shifting, sequencing, and divided attention (frontal lobe / dorsolateral prefrontal cortex) ((NEUR189)). ---

Speech & Motor Examination

  • Dysarthria Patterns: ((NEUR190)): Cerebellar dysarthria (scanning/staccato dysarthria) presents as slow, deliberate speech with equal emphasis on each syllable, sounding fragmented due to speech musculature incoordination.
  • MRC Muscle Power Grading & Standard Positioning: ([NEUR191, __NEUR192__, __NEUR193__, __NEUR194__]): - Grade 3 Power: Movement through the full range of motion against gravity, but unable to sustain against resistance ((NEUR191)). (Grade 2 = movement only with gravity eliminated). - Prone Position Testing: Used to assess neck, shoulder, hip extensors, and knee flexors. Shoulder abductors are not tested prone; they are optimally tested in a sitting position against gravity ((NEUR192)). - Hip Flexors: Evaluated in the sitting position by testing the iliopsoas against downward resistance on the distal thigh ((NEUR193)). - Shoulder Abductors: Evaluated in the sitting position, targeting the deltoid (and supraspinatus for initial phase) ((NEUR194)).
  • Peripheral Nerve and Muscle Testing in Upper/Lower Limbs: ([NEUR195, __NEUR196__, __NEUR197__, __NEUR198__, __NEUR199__, __NEUR200__]): - Shoulder Abduction Phases: The supraspinatus initiates abduction for the first 15° (suprascapular nerve), whereas the deltoid (axillary nerve) drives abduction from 15° to 90°. Axillary nerve injury spares initial 15° abduction ((NEUR195)). - Thumb Abduction: Evaluates the abductor pollicis brevis (APB), supplied by the recurrent branch of the median nerve ((NEUR196)). - Finger Adduction (Paper Test): Evaluates palmar interossei, supplied by the deep branch of the ulnar nerve ((NEUR197)). (Lumbricals flex MCP and extend IP joints). - Triceps Jerk: Mediated predominantly by the C6–C7 spinal segments (primarily C7) via the radial nerve ((NEUR198)). - Ankle Clonus: Sustained rhythmic contractions following sudden dorsiflexion indicate marked hyperexcitability and are graded as 4+ on the deep tendon reflex scale, pointing to an upper motor neuron (UMN) lesion ((NEUR199)). - Schaefer Sign: Elicited by squeezing the Achilles tendon, yielding an extensor plantar response indicative of corticospinal tract dysfunction ((NEUR200)). (Chaddock = stroking lateral foot below malleolus; Gordon = squeezing calf muscle). ---

Sensory Pathways & Higher Neurological Signs

  • Dermatomal Localization: ((NEUR201)): Sensory loss isolated exclusively to the middle finger localizes specifically to the C7 nerve root. (C6 supplies thumb/lateral forearm).
  • Romberg Test vs. Pronator Drift: ([NEUR202, __NEUR203__, __NEUR204__]): - Romberg Test: Evaluates the dorsal column–medial lemniscal pathway (conscious proprioception). Balance is maintained with eyes open but lost when eyes close (visual compensation removed). Does not primarily test cerebellar vermis/spinocerebellar tracts ((NEUR202)). - Pronator Drift Test: Detects subtle corticospinal tract (upper motor neuron) weakness. The affected arm gradually pronates and drifts downward due to relative weakness of supinators. Contralateral drift points to a corticospinal lesion in the opposite cerebral hemisphere ((NEUR203)).
  • Tremor Pathophysiology: ((NEUR204)): Isolated rhythmic tremors originate from abnormalities of the cerebellothalamocortical pathway, distinguishing them from basal ganglia disorders (nigrostriatal pathway) that cause hypokinetic/hyperkinetic extrapyramidal movement disorders like parkinsonism, dystonia, or chorea.